Prediction Of Great Future Of Gliomas In Neurological
World Neurosurgery Research · 2026
DOI: 10.52338/wnsr.2026.6010 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Neurosurgery Research, 2026. Verfasst von Bernardino Saccomanni. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
dehydrogenase (IDH) genotype, O6-methylguanine-DNAmethyltransferase (MGMT) promoter methylation status, 1p19q codeletion, survival prediction, treatment response, pseudo-progression and progression, and the glioma functional network.IN THIS REVIEW THERE ARE NOT FIGURES AND TABLES.Glioblastoma (GB), previously known as GB multiforme (GBM) is one of the most aggressive types of brain cancer, which is characterized by its rapid development, poor response to therapy and low rate of survival (12).AI is used in glioblastoma detection, for the prediction of the overall survival (OS) rate, and for determining the MGMT promoter methylation status, which is a mutation positively associated with an improved prognosis and temozolomide treatment response.AI is also used to determine tumor
Zitieren
APA
Saccomanni, B. (2026). Prediction Of Great Future Of Gliomas In Neurological. World Neurosurgery Research. https://doi.org/10.52338/wnsr.2026.6010
Vancouver
Saccomanni B. Prediction Of Great Future Of Gliomas In Neurological. World Neurosurgery Research. 2026. doi:10.52338/wnsr.2026.6010
BibTeX
@article{Saccomanni2026,
author = {Saccomanni, Bernardino},
title = {Prediction Of Great Future Of Gliomas In Neurological},
journal = {World Neurosurgery Research},
year = {2026},
doi = {10.52338/wnsr.2026.6010}
}
EUVIMED